High levels of T-cells from common cold coronaviruses can provide protection against COVID-19, an Imperial College London study published on January 10 found, which could inform approaches for second-generation vaccines.
The Omicron variant of the virus that causes COVID-19 likely acquired at least one of its mutations by picking up a snippet of genetic material from another virus – possibly one that causes the common cold – present in the same infected cells, according to researchers.
People who received the one-dose Johnson & Johnson Covid-19 vaccine may need a booster shot to fend off some of the worrisome coronavirus variants now spreading worldwide, a study suggests.
While a failed ebola drug helped treat hospitalized Covid-19 patients, the common cold virus could become key in treating advanced unresectable cancers.
Amazon’s Project Gesundheit, a multi-year project including more than 100 people, is focused on finding a cure for the common cold.
Vernalis plc announces today that the US Food and Drug Administration issued a Complete Response Letter (CRL) regarding the New Drug Application for CCP-07.
Commonly used drugs for problems such as colds and heart disease have long been linked to cognitive impairment and dementia. New evidence may help explain the connection.
U.S. adults who sleep no more than five hours per night or who have a diagnosed sleep disorder are more likely to have suffered a recent cold than those who sleep more.